0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Pain Medication Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15P14594
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Veterinary Pain Medication Market Research Report 2023
BUY CHAPTERS

Global Veterinary Pain Medication Market Research Report 2025

Code: QYRE-Auto-15P14594
Report
May 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Pain Medication Market Size

The global market for Veterinary Pain Medication was valued at US$ 5218 million in the year 2024 and is projected to reach a revised size of US$ 7955 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Veterinary Pain Medication Market

Veterinary Pain Medication Market

North American market for Veterinary Pain Medication is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Veterinary Pain Medication is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Veterinary Pain Medication include Boehringer Ingelheim, Elanco, Zoetis, Baxter, Halyard, Endo International, Forest Laboratories, Medtronic, Bayer Pharma AG, Ceva Sante Animale, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Pain Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Pain Medication.
The Veterinary Pain Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Pain Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Pain Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Pain Medication Market Report

Report Metric Details
Report Name Veterinary Pain Medication Market
Accounted market size in year US$ 5218 million
Forecasted market size in 2031 US$ 7955 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Elanco, Zoetis, Baxter, Halyard, Endo International, Forest Laboratories, Medtronic, Bayer Pharma AG, Ceva Sante Animale, Ringpu Bio-technology, Ruicheng Lvman Biological Pharmaceutical Co., Ltd., Norbrook Laboratories, Merck & Co, Bostonscientific, Lilly, Pfizer, Harbin Bolai Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Pain Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Pain Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary Pain Medication Market growing?

Ans: The Veterinary Pain Medication Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Veterinary Pain Medication Market size in 2031?

Ans: The Veterinary Pain Medication Market size in 2031 will be US$ 7955 million.

Who are the main players in the Veterinary Pain Medication Market report?

Ans: The main players in the Veterinary Pain Medication Market are Boehringer Ingelheim, Elanco, Zoetis, Baxter, Halyard, Endo International, Forest Laboratories, Medtronic, Bayer Pharma AG, Ceva Sante Animale, Ringpu Bio-technology, Ruicheng Lvman Biological Pharmaceutical Co., Ltd., Norbrook Laboratories, Merck & Co, Bostonscientific, Lilly, Pfizer, Harbin Bolai Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Veterinary Pain Medication Market report?

Ans: The Applications covered in the Veterinary Pain Medication Market report are Veterinary Hospitals, Veterinary Clinics, Others

What are the Type segmentation covered in the Veterinary Pain Medication Market report?

Ans: The Types covered in the Veterinary Pain Medication Market report are Injection Medicines, Oral Medicines

Recommended Reports

Veterinary Healthcare

Pain Management

Veterinary Devices

1 Veterinary Pain Medication Market Overview
1.1 Product Definition
1.2 Veterinary Pain Medication by Type
1.2.1 Global Veterinary Pain Medication Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection Medicines
1.2.3 Oral Medicines
1.3 Veterinary Pain Medication by Application
1.3.1 Global Veterinary Pain Medication Market Value by Application (2024 VS 2031)
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Global Veterinary Pain Medication Market Size Estimates and Forecasts
1.4.1 Global Veterinary Pain Medication Revenue 2020-2031
1.4.2 Global Veterinary Pain Medication Sales 2020-2031
1.4.3 Global Veterinary Pain Medication Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Pain Medication Market Competition by Manufacturers
2.1 Global Veterinary Pain Medication Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Pain Medication Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Pain Medication Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Pain Medication, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Pain Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Pain Medication, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Pain Medication, Date of Enter into This Industry
2.8 Global Veterinary Pain Medication Market Competitive Situation and Trends
2.8.1 Global Veterinary Pain Medication Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Pain Medication Players Market Share by Revenue
2.8.3 Global Veterinary Pain Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Pain Medication Market Scenario by Region
3.1 Global Veterinary Pain Medication Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Pain Medication Sales by Region: 2020-2031
3.2.1 Global Veterinary Pain Medication Sales by Region: 2020-2025
3.2.2 Global Veterinary Pain Medication Sales by Region: 2026-2031
3.3 Global Veterinary Pain Medication Revenue by Region: 2020-2031
3.3.1 Global Veterinary Pain Medication Revenue by Region: 2020-2025
3.3.2 Global Veterinary Pain Medication Revenue by Region: 2026-2031
3.4 North America Veterinary Pain Medication Market Facts & Figures by Country
3.4.1 North America Veterinary Pain Medication Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Pain Medication Sales by Country (2020-2031)
3.4.3 North America Veterinary Pain Medication Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Pain Medication Market Facts & Figures by Country
3.5.1 Europe Veterinary Pain Medication Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Pain Medication Sales by Country (2020-2031)
3.5.3 Europe Veterinary Pain Medication Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Pain Medication Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Pain Medication Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Pain Medication Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Pain Medication Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Pain Medication Market Facts & Figures by Country
3.7.1 Latin America Veterinary Pain Medication Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Pain Medication Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Pain Medication Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Pain Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Pain Medication Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Pain Medication Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Pain Medication Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Pain Medication Sales by Type (2020-2031)
4.1.1 Global Veterinary Pain Medication Sales by Type (2020-2025)
4.1.2 Global Veterinary Pain Medication Sales by Type (2026-2031)
4.1.3 Global Veterinary Pain Medication Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Pain Medication Revenue by Type (2020-2031)
4.2.1 Global Veterinary Pain Medication Revenue by Type (2020-2025)
4.2.2 Global Veterinary Pain Medication Revenue by Type (2026-2031)
4.2.3 Global Veterinary Pain Medication Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Pain Medication Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Pain Medication Sales by Application (2020-2031)
5.1.1 Global Veterinary Pain Medication Sales by Application (2020-2025)
5.1.2 Global Veterinary Pain Medication Sales by Application (2026-2031)
5.1.3 Global Veterinary Pain Medication Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Pain Medication Revenue by Application (2020-2031)
5.2.1 Global Veterinary Pain Medication Revenue by Application (2020-2025)
5.2.2 Global Veterinary Pain Medication Revenue by Application (2026-2031)
5.2.3 Global Veterinary Pain Medication Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Pain Medication Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Veterinary Pain Medication Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Company Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Elanco Veterinary Pain Medication Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Company Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis Veterinary Pain Medication Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Veterinary Pain Medication Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Halyard
6.5.1 Halyard Company Information
6.5.2 Halyard Description and Business Overview
6.5.3 Halyard Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Halyard Veterinary Pain Medication Product Portfolio
6.5.5 Halyard Recent Developments/Updates
6.6 Endo International
6.6.1 Endo International Company Information
6.6.2 Endo International Description and Business Overview
6.6.3 Endo International Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Endo International Veterinary Pain Medication Product Portfolio
6.6.5 Endo International Recent Developments/Updates
6.7 Forest Laboratories
6.7.1 Forest Laboratories Company Information
6.7.2 Forest Laboratories Description and Business Overview
6.7.3 Forest Laboratories Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Forest Laboratories Veterinary Pain Medication Product Portfolio
6.7.5 Forest Laboratories Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Company Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Medtronic Veterinary Pain Medication Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 Bayer Pharma AG
6.9.1 Bayer Pharma AG Company Information
6.9.2 Bayer Pharma AG Description and Business Overview
6.9.3 Bayer Pharma AG Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Pharma AG Veterinary Pain Medication Product Portfolio
6.9.5 Bayer Pharma AG Recent Developments/Updates
6.10 Ceva Sante Animale
6.10.1 Ceva Sante Animale Company Information
6.10.2 Ceva Sante Animale Description and Business Overview
6.10.3 Ceva Sante Animale Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ceva Sante Animale Veterinary Pain Medication Product Portfolio
6.10.5 Ceva Sante Animale Recent Developments/Updates
6.11 Ringpu Bio-technology
6.11.1 Ringpu Bio-technology Company Information
6.11.2 Ringpu Bio-technology Description and Business Overview
6.11.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ringpu Bio-technology Veterinary Pain Medication Product Portfolio
6.11.5 Ringpu Bio-technology Recent Developments/Updates
6.12 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
6.12.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
6.12.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
6.12.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Norbrook Laboratories
6.13.1 Norbrook Laboratories Company Information
6.13.2 Norbrook Laboratories Description and Business Overview
6.13.3 Norbrook Laboratories Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Norbrook Laboratories Veterinary Pain Medication Product Portfolio
6.13.5 Norbrook Laboratories Recent Developments/Updates
6.14 Merck & Co
6.14.1 Merck & Co Company Information
6.14.2 Merck & Co Description and Business Overview
6.14.3 Merck & Co Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Merck & Co Veterinary Pain Medication Product Portfolio
6.14.5 Merck & Co Recent Developments/Updates
6.15 Bostonscientific
6.15.1 Bostonscientific Company Information
6.15.2 Bostonscientific Description and Business Overview
6.15.3 Bostonscientific Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bostonscientific Veterinary Pain Medication Product Portfolio
6.15.5 Bostonscientific Recent Developments/Updates
6.16 Lilly
6.16.1 Lilly Company Information
6.16.2 Lilly Description and Business Overview
6.16.3 Lilly Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lilly Veterinary Pain Medication Product Portfolio
6.16.5 Lilly Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Company Information
6.17.2 Pfizer Description and Business Overview
6.17.3 Pfizer Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Pfizer Veterinary Pain Medication Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
6.18 Harbin Bolai Pharmaceutical Co., Ltd.
6.18.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information
6.18.2 Harbin Bolai Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
6.18.5 Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Pain Medication Industry Chain Analysis
7.2 Veterinary Pain Medication Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Pain Medication Production Mode & Process Analysis
7.4 Veterinary Pain Medication Sales and Marketing
7.4.1 Veterinary Pain Medication Sales Channels
7.4.2 Veterinary Pain Medication Distributors
7.5 Veterinary Pain Medication Customer Analysis
8 Veterinary Pain Medication Market Dynamics
8.1 Veterinary Pain Medication Industry Trends
8.2 Veterinary Pain Medication Market Drivers
8.3 Veterinary Pain Medication Market Challenges
8.4 Veterinary Pain Medication Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Pain Medication Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Pain Medication Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Pain Medication Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Pain Medication Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Pain Medication Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Pain Medication Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Pain Medication Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Pain Medication Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Pain Medication, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Pain Medication, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Pain Medication, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Pain Medication, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Pain Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Pain Medication as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Pain Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Pain Medication Sales by Region (2020-2025) & (K Units)
 Table 18. Global Veterinary Pain Medication Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Pain Medication Sales by Region (2026-2031) & (K Units)
 Table 20. Global Veterinary Pain Medication Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Pain Medication Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Pain Medication Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Pain Medication Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Pain Medication Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Pain Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Pain Medication Sales by Country (2020-2025) & (K Units)
 Table 27. North America Veterinary Pain Medication Sales by Country (2026-2031) & (K Units)
 Table 28. North America Veterinary Pain Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Pain Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Pain Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Pain Medication Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Veterinary Pain Medication Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Veterinary Pain Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Pain Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Pain Medication Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Pain Medication Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Veterinary Pain Medication Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Veterinary Pain Medication Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Pain Medication Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Pain Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Pain Medication Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Veterinary Pain Medication Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Veterinary Pain Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Pain Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Pain Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Pain Medication Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Veterinary Pain Medication Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Veterinary Pain Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Pain Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Pain Medication Sales (K Units) by Type (2020-2025)
 Table 51. Global Veterinary Pain Medication Sales (K Units) by Type (2026-2031)
 Table 52. Global Veterinary Pain Medication Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Pain Medication Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Pain Medication Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Pain Medication Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Pain Medication Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Pain Medication Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Pain Medication Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Pain Medication Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Pain Medication Sales (K Units) by Application (2020-2025)
 Table 61. Global Veterinary Pain Medication Sales (K Units) by Application (2026-2031)
 Table 62. Global Veterinary Pain Medication Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Pain Medication Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Pain Medication Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Pain Medication Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Pain Medication Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Pain Medication Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Pain Medication Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Pain Medication Price (US$/Unit) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Veterinary Pain Medication Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Elanco Company Information
 Table 76. Elanco Description and Business Overview
 Table 77. Elanco Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Elanco Veterinary Pain Medication Product
 Table 79. Elanco Recent Developments/Updates
 Table 80. Zoetis Company Information
 Table 81. Zoetis Description and Business Overview
 Table 82. Zoetis Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zoetis Veterinary Pain Medication Product
 Table 84. Zoetis Recent Developments/Updates
 Table 85. Baxter Company Information
 Table 86. Baxter Description and Business Overview
 Table 87. Baxter Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Baxter Veterinary Pain Medication Product
 Table 89. Baxter Recent Developments/Updates
 Table 90. Halyard Company Information
 Table 91. Halyard Description and Business Overview
 Table 92. Halyard Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Halyard Veterinary Pain Medication Product
 Table 94. Halyard Recent Developments/Updates
 Table 95. Endo International Company Information
 Table 96. Endo International Description and Business Overview
 Table 97. Endo International Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Endo International Veterinary Pain Medication Product
 Table 99. Endo International Recent Developments/Updates
 Table 100. Forest Laboratories Company Information
 Table 101. Forest Laboratories Description and Business Overview
 Table 102. Forest Laboratories Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Forest Laboratories Veterinary Pain Medication Product
 Table 104. Forest Laboratories Recent Developments/Updates
 Table 105. Medtronic Company Information
 Table 106. Medtronic Description and Business Overview
 Table 107. Medtronic Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Medtronic Veterinary Pain Medication Product
 Table 109. Medtronic Recent Developments/Updates
 Table 110. Bayer Pharma AG Company Information
 Table 111. Bayer Pharma AG Description and Business Overview
 Table 112. Bayer Pharma AG Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bayer Pharma AG Veterinary Pain Medication Product
 Table 114. Bayer Pharma AG Recent Developments/Updates
 Table 115. Ceva Sante Animale Company Information
 Table 116. Ceva Sante Animale Description and Business Overview
 Table 117. Ceva Sante Animale Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ceva Sante Animale Veterinary Pain Medication Product
 Table 119. Ceva Sante Animale Recent Developments/Updates
 Table 120. Ringpu Bio-technology Company Information
 Table 121. Ringpu Bio-technology Description and Business Overview
 Table 122. Ringpu Bio-technology Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Ringpu Bio-technology Veterinary Pain Medication Product
 Table 124. Ringpu Bio-technology Recent Developments/Updates
 Table 125. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
 Table 126. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product
 Table 129. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Norbrook Laboratories Company Information
 Table 131. Norbrook Laboratories Description and Business Overview
 Table 132. Norbrook Laboratories Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Norbrook Laboratories Veterinary Pain Medication Product
 Table 134. Norbrook Laboratories Recent Developments/Updates
 Table 135. Merck & Co Company Information
 Table 136. Merck & Co Description and Business Overview
 Table 137. Merck & Co Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Merck & Co Veterinary Pain Medication Product
 Table 139. Merck & Co Recent Developments/Updates
 Table 140. Bostonscientific Company Information
 Table 141. Bostonscientific Description and Business Overview
 Table 142. Bostonscientific Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bostonscientific Veterinary Pain Medication Product
 Table 144. Bostonscientific Recent Developments/Updates
 Table 145. Lilly Company Information
 Table 146. Lilly Description and Business Overview
 Table 147. Lilly Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Lilly Veterinary Pain Medication Product
 Table 149. Lilly Recent Developments/Updates
 Table 150. Pfizer Company Information
 Table 151. Pfizer Description and Business Overview
 Table 152. Pfizer Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Pfizer Veterinary Pain Medication Product
 Table 154. Pfizer Recent Developments/Updates
 Table 155. Harbin Bolai Pharmaceutical Co., Ltd. Company Information
 Table 156. Harbin Bolai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 157. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product
 Table 159. Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Veterinary Pain Medication Distributors List
 Table 163. Veterinary Pain Medication Customers List
 Table 164. Veterinary Pain Medication Market Trends
 Table 165. Veterinary Pain Medication Market Drivers
 Table 166. Veterinary Pain Medication Market Challenges
 Table 167. Veterinary Pain Medication Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Pain Medication
 Figure 2. Global Veterinary Pain Medication Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Pain Medication Market Share by Type: 2024 & 2031
 Figure 4. Injection Medicines Product Picture
 Figure 5. Oral Medicines Product Picture
 Figure 6. Global Veterinary Pain Medication Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Veterinary Pain Medication Market Share by Application: 2024 & 2031
 Figure 8. Veterinary Hospitals
 Figure 9. Veterinary Clinics
 Figure 10. Others
 Figure 11. Global Veterinary Pain Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Veterinary Pain Medication Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Veterinary Pain Medication Sales (2020-2031) & (K Units)
 Figure 14. Global Veterinary Pain Medication Average Price (US$/Unit) & (2020-2031)
 Figure 15. Veterinary Pain Medication Report Years Considered
 Figure 16. Veterinary Pain Medication Sales Share by Manufacturers in 2024
 Figure 17. Global Veterinary Pain Medication Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Veterinary Pain Medication Players: Market Share by Revenue in Veterinary Pain Medication in 2024
 Figure 19. Veterinary Pain Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Veterinary Pain Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Veterinary Pain Medication Sales Market Share by Country (2020-2031)
 Figure 22. North America Veterinary Pain Medication Revenue Market Share by Country (2020-2031)
 Figure 23. United States Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Veterinary Pain Medication Sales Market Share by Country (2020-2031)
 Figure 26. Europe Veterinary Pain Medication Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Veterinary Pain Medication Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Veterinary Pain Medication Revenue Market Share by Region (2020-2031)
 Figure 34. China Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Veterinary Pain Medication Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Veterinary Pain Medication Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Veterinary Pain Medication Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Veterinary Pain Medication Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Veterinary Pain Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Veterinary Pain Medication by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Veterinary Pain Medication by Type (2020-2031)
 Figure 53. Global Veterinary Pain Medication Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Veterinary Pain Medication by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Veterinary Pain Medication by Application (2020-2031)
 Figure 56. Global Veterinary Pain Medication Price (US$/Unit) by Application (2020-2031)
 Figure 57. Veterinary Pain Medication Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS